海角破解版

EasySep? Human PE Positive Selection Kit II

Immunomagnetic positive selection of PE-conjugated antibody-labeled human cells

EasySep? Human PE Positive Selection Kit II

Immunomagnetic positive selection of PE-conjugated antibody-labeled human cells

Catalog #
(Select a product)
Immunomagnetic positive selection of PE-conjugated antibody-labeled human cells
Request Pricing Request Pricing

Product Advantages


  • Fast and easy-to-use

  • No columns required

What's Included

  • EasySep? Human PE Positive Selection Kit II (Catalog #17664)
    • EasySep? PE Selection Cocktail, 1 mL
    • Anti-Human CD32 FcR Blocker, 1 mL
    • EasySep? Dextran RapidSpheres?, 1 mL
    • RoboSep? Vial For Primary Conjugated Antibody (not required for manual use), 1 vial
  • EasySep? Human PE Positive Selection Kit II (Catalog #17694)
    • EasySep? Human PE Positive Selection Kit II (Catalog #17664) x 5
  • RoboSep? Human PE Positive Selection Kit II (Catalog #17664RF)
    • EasySep? PE Selection Cocktail, 1 mL
    • Anti-Human CD32 FcR Blocker, 1 mL
    • EasySep? Dextran RapidSpheres?, 1 mL
    • RoboSep? Vial For Primary Conjugated Antibody (not required for manual use), 1 vial
    • RoboSep? Buffer (Catalog #20104)
    • RoboSep? Filter Tips (Catalog #20125) x 2
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Isolate highly purified phycoerythrin (PE)-conjugated antibody-labeled cells from fresh or previously frozen human peripheral blood mononuclear cells (PBMCs) or other single-cell suspensions by immunomagnetic positive selection, with the EasySep? PE Positive Selection Kit II. Widely used in published research for more than 20 years, EasySep? combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.

In this EasySep? positive selection procedure, desired cells are labeled with antibody complexes recognizing PE and magnetic particles. Labeled cells are separated using an EasySep? magnet and by simply pouring or pipetting off the unwanted cells. The cells of interest remain in the tube. Following magnetic cell isolation, the desired PE positive cells are ready for downstream applications such as flow cytometry, cell culture, or cell-based assays.

For highly purified particle-free cells, we recommend the EasySep? Release Human PE Positive Selection Kit (Catalog #17654).

Learn more about how immunomagnetic EasySep? technology works or how to fully automate immunomagnetic cell isolation with RoboSep?. Explore additional products optimized for your workflow, including culture media, supplements, antibodies, and more.

Magnet Compatibility
? EasySep? Magnet (Catalog #18000)
? “The Big Easy” EasySep? Magnet (Catalog #18001)
? EasyEights? EasySep? Magnet (Catalog #18103)
? RoboSep?-S (Catalog #21000)
Subtype
Cell Isolation Kits
Cell Type
B Cells, Dendritic Cells, Granulocytes and Subsets, Hematopoietic Stem and Progenitor Cells, Macrophages, Marrow Stromal Cells, Mesenchymal Stem and Progenitor Cells, Monocytes, Mononuclear Cells, Myeloid Cells, NK Cells, Other, Plasma, T Cells
Species
Human
Sample Source
Buffy Coat, Cord Blood, Leukapheresis, Other, PBMC
Selection Method
Positive
Application
Cell Isolation
Brand
EasySep, RoboSep
Area of Interest
Immunology

Data Figures

Starting with human PBMCs, the purities of the start and final isolated fractions in the above example are 59.1% and 98.7%, respectively, using a PE-conjugated anti-human CD3 antibody and EasySep? Human PE Positive Selection Kit II.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
17664RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17694, 17664
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17664RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17664RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17664RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17664RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17694, 17664
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17694, 17664
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17664
Lot #
All
Language
English

Resources and Publications

Publications (4)

Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells World Journal of Stem Cells 2025 Feb

Abstract

BACKGROUNDSepsis is a severe illness characterized by systemic and multiorgan reactive responses and damage. However, the impact of sepsis on the bone marrow, particularly on bone marrow mesenchymal stem cells (BMSCs), is less reported. BMSCs are critical stromal cells in the bone marrow microenvironment that maintain bone stability and hematopoietic homeostasis; however, the impairment caused by sepsis remains unknown.AIMTo investigate the effects of sepsis on BMSCs and the underlying mechanisms.METHODSBMSCs were obtained from healthy donors and patients with sepsis. We compared the self-renewal capacity, differentiation potential, and hematopoietic supportive ability in vitro. Senescence of septic BMSCs was assessed using β-galactosidase staining, senescence-associated secretory phenotype, intracellular reactive oxygen species levels, and the expression of P16 and P21. Finally, the changes in septic BMSCs after nicotinamide adenine dinucleotide (NAD) treatment were evaluated.RESULTSSeptic BMSCs showed decreased proliferation and self-renewal, bias towards adipogenic differentiation, and weakened osteogenic differentiation. Additionally, hematopoietic supportive capacity declines in sepsis. The levels of aging markers were significantly higher in the septic BMSCs. After NAD treatment, the proliferation capacity of septic BMSCs showed a recovery trend, with increased osteogenic and hematopoietic supportive capacities. Sepsis resulted in decreased expression of sirtuin 3 (SIRT3) in BMSCs, whereas NAD treatment restored SIRT3 expression, enhanced superoxide dismutase enzyme activity, reduced intracellular reactive oxygen species levels, maintained mitochondrial stability and function, and ultimately rejuvenated septic BMSCs.CONCLUSIONSepsis accelerates the aging of BMSCs, as evidenced by a decline in self-renewal and osteogenic capabilities, as well as weakened hematopoietic support functions. These deficiencies can be effectively reversed via the NAD/SIRT3/superoxide dismutase pathway.
Influence of donor–recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation HemaSphere 2024 May

Abstract

AbstractImmunodeficient mouse models are widely used for the assessment of human normal and leukemic stem cells. Despite the advancements over the years, reproducibility, as well as the differences in the engraftment of human cells in recipient mice remains to be fully resolved. Here, we used various immunodeficient mouse models to characterize the effect of donor–recipient sex on the engraftment of the human leukemic and healthy cells. Donor human cells and recipient immunodeficient mice demonstrate sex‐specific engraftment levels with significant differences observed in the lineage output of normal CD34+ hematopoietic stem and progenitor cells upon xenotransplantation. Intriguingly, human female donor cells display heightened sensitivity to the recipient mice's gender, influencing their proliferation and resulting in significantly increased engraftment in female recipient mice. Our study underscores the intricate interplay taking place between donor and recipient characteristics, shedding light on important considerations for future studies, particularly in the context of pre‐clinical research.
Clostridium perfringens $\alpha$-toxin up-regulates plasma membrane CD11b expression on murine neutrophils by changing intracellular localization. M. Takehara et al. Biochimica et biophysica acta. Biomembranes 2022 dec

Abstract

Gas gangrene caused by Clostridium perfringens type A infection is a highly lethal infection of soft tissue characterized by rapid spread of tissue necrosis. This tissue destruction is related to profound attenuation of blood flow accompanied by formation of platelet-leukocyte aggregates in the blood vessels. Several studies have identified $\alpha$-toxin, which has both sphingomyelinase and phospholipase C activities, as a major virulence factor in the aggregate formation via activation of the platelet gpIIbIIIa. Here, we show that $\alpha$-toxin greatly and rapidly increases plasma membrane localization of CD11b, which binds to the platelet gpIIbIIIa via fibrinogen, in mouse neutrophils. Interestingly, short-term treatment of $\alpha$-toxin has little effect on gene expression profiles in neutrophils, and the toxin does not change the total protein expression levels of CD11b in whole cell lysates. The following analysis demonstrated that CD11b localizes to intracellular vesicles in intact cells, but the localization changed to the cytoplasmic membrane in $\alpha$-toxin-treated cells. These results suggest that CD11b is recruited to the cytoplasmic membrane by $\alpha$-toxin. Previously, we reported that $\alpha$-toxin promotes the formation of ceramide by its sphingomyelinase activity in mouse neutrophils. Interestingly, a synthetic cell-permeable ceramide analog, C2-ceramide, increases plasma membrane localization of CD11b, suggesting that ceramide production by $\alpha$-toxin recruits CD11b to the cytoplasmic membrane to promote platelet-leukocyte aggregation. Together, our results illustrate that the increase of cell membrane CD11b expression by $\alpha$-toxin might be crucial for the pathogenesis of C. perfringens to promote formation of platelet-leukocyte aggregates, leading to rapid tissue necrosis due to ischemia.